Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

Cancer Cell

Volumn 10, Issue 6, 2006, Pages 529-541

  Chin, Koei ^a   DeVries, Sandy ^a   Fridlyand, Jane ^a   Spellman, Paul T ^b   Roydasgupta, Ritu ^a   Kuo, Wen Lin ^a,b   Lapuk, Anna ^a,b   Neve, Richard M ^a,b   Qian, Zuwei ^d   Ryder, Tom ^d   Chen, Fanqing ^b   Feiler, Heidi ^a,b   Tokuyasu, Taku ^a   Kingsley, Chris ^a   Dairkee, Shanaz ^c   Meng, Zhenhang ^c   Chew, Karen ^a   Pinkel, Daniel ^a   Jain, Ajay ^a   Ljung, Britt Marie ^a   Esserman, Laura ^a   Albertson, Donna G ^a   Waldman, Frederic M ^a   Gray, Joe W ^a,b   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d Thermo Fisher Scientific   (United States)

Author keywords

CELLCYCLE; HUMDISEASE

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1;

ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CELL METABOLISM; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC LINKAGE; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 33845191779     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2006.10.009     Document Type: Article

References (76)

1. Akagi K., Suzuki T., Stephens R.M., Jenkins N.A., and Copeland N.G. RTCGD: Retroviral tagged cancer gene database. Nucleic Acids Res. 32 (2004) D523-D527
2. Al-Kuraya K., Schraml P., Torhorst J., Tapia C., Zaharieva B., Novotny H., Spichtin H., Maurer R., Mirlacher M., Kochli O., et al. Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res. 64 (2004) 8534-8540
3. Albertson D.G., Collins C., McCormick F., and Gray J.W. Chromosome aberrations in solid tumors. Nat. Genet. 34 (2003) 369-376
4. Babu J.R., Jeganathan K.B., Baker D.J., Wu X., Kang-Decker N., and van Deursen J.M. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J. Cell Biol. 160 (2003) 341-353
5. Barlund M., Tirkkonen M., Forozan F., Tanner M.M., Kallioniemi O., and Kallioniemi A. Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions. Genes Chromosomes Cancer 20 (1997) 372-376
6. Barlund M., Monni O., Kononen J., Cornelison R., Torhorst J., Sauter G., Kallioniemi O.-P., and Kallioniemi A. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res. 60 (2000) 5340-5344
7. Baylin S.B., and Herman J.G. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends Genet. 16 (2000) 168-174
8. Bergamaschi A., Kim Y.H., Wang P., Sorlie T., Hernandez-Boussard T., Lonning P.E., Tibshirani R., Borresen-Dale A.L., and Pollack J.R. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer 45 (2006) 1033-1040
9. Beissbarth T., and Speed T.P. GOstat: Find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 20 (2004) 1464-1465
10. Blegen H., Will J.S., Ghadimi B.M., Nash H.P., Zetterberg A., Auer G., and Ried T. DNA amplifications and aneuploidy, high proliferative activity and impaired cell cycle control characterize breast carcinomas with poor prognosis. Anal. Cell. Pathol. 25 (2003) 103-114
11. Braun B.S., and Shannon K. The sum is greater than the FGFR1 partner. Cancer Cell 5 (2004) 203-204
12. Callagy G., Pharoah P., Chin S.F., Sangan T., Daigo Y., Jackson L., and Caldas C. Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays. J. Pathol. 205 (2005) 388-396
13. Cheng K.W., Lahad J.P., Kuo W.L., Lapuk A., Yamada K., Auersperg N., Liu J., Smith-McCune K., Lu K.H., Fishman D., et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat. Med. 10 (2004) 1251-1256
14. Chin K., de Solorzano C.O., Knowles D., Jones A., Chou W., Rodriguez E.G., Kuo W.L., Ljung B.M., Chew K., Myambo K., et al. In situ analyses of genome instability in breast cancer. Nat. Genet. 36 (2004) 984-988
15. Clairmont C.A., Narayanan L., Sun K.W., Glazer P.M., and Sweasy J.B. The Tyr-265-to-Cys mutator mutant of DNA polymerase beta induces a mutator phenotype in mouse LN12 cells. Proc. Natl. Acad. Sci. USA 96 (1999) 9580-9585
16. Deutschbauer A.M., Jaramillo D.F., Proctor M., Kumm J., Hillenmeyer M.E., Davis R.W., Nislow C., and Giaever G. Mechanisms of haploinsufficiency revealed by genome-wide profiling in yeast. Genetics 169 (2005) 1915-1925
17. Esteva F.J., Sahin A.A., Cristofanilli M., Coombes K., Lee S.J., Baker J., Cronin M., Walker M., Watson D., Shak S., and Hortobagyi G.N. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy. Clin. Cancer Res. 11 (2005) 3315-3319
18. Fraser M.M., Watson P.M., Fraig M.M., Kelley J.R., Nelson P.S., Boylan A.M., Cole D.J., and Watson D.K. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability. Cancer Res. 65 (2005) 6228-6236
19. Fridlyand J., Snijders A.M., Ylstra B., Li H., Olshen A., Segraves R., Dairkee S., Tokuyasu T., Ljung B.M., Jain A.N., et al. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 6 (2006) 96
20. Gehrmann M., Marienhagen J., Eichholtz-Wirth H., Fritz E., Ellwart J., Jaattela M., Zilch T., and Multhoff G. Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: Protection against radiation-induced effects and target structure for natural killer cells. Cell Death Differ. 12 (2005) 38-51
21. Gelsi-Boyer V., Orsetti B., Cervera N., Finetti P., Sircoulomb F., Rouge C., Lasorsa L., Letessier A., Ginestier C., Monville F., et al. Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol. Cancer Res. 3 (2005) 655-667
22. Gianni L., Zambetti M., Clark K., Baker J., Cronin M., Wu J., Mariani G., Rodriguez J., Carcangiu M., Watson D., et al. Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer. J. Clin. Oncol. 23 (2005) 7265-7277
23. Greten F.R., and Karin M. The IKK/NF-κB activation pathway-A target for prevention and treatment of cancer. Cancer Lett. 206 (2004) 193-199
24. Hackett C.S., Hodgson J.G., Law M.E., Fridlyand J., Osoegawa K., de Jong P.J., Nowak N.J., Pinkel D., Albertson D.G., Jain A., et al. Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors. Cancer Res. 63 (2003) 5266-5273
25. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
26. Hartigan J.A. Clustering Algorithms (1975), Wiley, New York
27. Hinds P.W., Dowdy S.F., Eaton E.N., Arnold A., and Weinberg R.A. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA 91 (1994) 709-713
28. Hodgson G., Hager J.H., Volik S., Hariono S., Wernick M., Moore D., Nowak N., Albertson D.G., Pinkel D., Collins C., et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet. 29 (2001) 459-464
29. Huang G., Krig S., Kowbel D., Xu H., Hyun B., Volik S., Feuerstein B., Mills G.B., Stokoe D., Yaswen P., and Collins C. ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction. Hum. Mol. Genet. 14 (2005) 3219-3225
30. Hyman E., Kauraniemi P., Hautaniemi S., Wolf M., Mousses S., Rozenblum E., Ringner M., Sauter G., Monni O., Elkahloun A., et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 62 (2002) 6240-6245
31. Irizarry R., Bolstad B., Collin F., Cope L., Hobbs B., and Speed T. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31 (2003) e15
32. Isola J.J., Kallioniemi O.P., Chu L.W., Fuqua S.A., Hilsenbeck S.G., Osborne C.K., and Waldman F.M. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am. J. Pathol. 147 (1995) 905-911
33. Jain A.N., Chin K., Borresen-Dale A.L., Erikstein B.K., Eynstein Lonning P., Kaaresen R., and Gray J.W. Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. Proc. Natl. Acad. Sci. USA 98 (2001) 7952-7957
34. Jain A.N., Tokuyasu T.A., Snijders A.M., Segraves R., Albertson D.G., and Pinkel D. Fully automatic quantification of microarray image data. Genome Res. 12 (2002) 325-332
35. Jones P.A. Overview of cancer epigenetics. Semin. Hematol. 42 (2005) S3-S8
36. Kallioniemi O.P., Kallioniemi A., Kurisu W., Thor A., Chen L.C., Smith H.S., Waldman F.M., Pinkel D., and Gray J.W. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. USA 89 (1992) 5321-5325
37. Kallioniemi A., Kallioniemi O.P., Piper J., Tanner M., Stokke T., Chen L., Smith H.S., Pinkel D., Gray J.W., and Waldman F.M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. USA 91 (1994) 2156-2160
38. Kauraniemi P., Barlund M., Monni O., and Kallioniemi A. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res. 61 (2001) 8235-8240
39. Kauraniemi P., Kuukasjarvi T., Sauter G., and Kallioniemi A. Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer. Am. J. Pathol. 163 (2003) 1979-1984
40. Knuutila S., Autio K., and Aalto Y. Online access to CGH data of DNA sequence copy number changes. Am. J. Pathol. 157 (2000) 689
41. Lam L.T., Davis R.E., Pierce J., Hepperle M., Xu Y., Hottelet M., Nong Y., Wen D., Adams J., Dang L., and Staudt L.M. Small molecule inhibitors of IκB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin. Cancer Res. 11 (2005) 28-40
42. Loo L.W., Grove D.I., Williams E.M., Neal C.L., Cousens L.A., Schubert E.L., Holcomb I.N., Massa H.F., Glogovac J., Li C.I., et al. Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res. 64 (2004) 8541-8549
43. Mazzocca A., Coppari R., De Franco R., Cho J.Y., Libermann T.A., Pinzani M., and Toker A. A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res. 65 (2005) 4728-4738
44. Naylor T.L., Greshock J., Wang Y., Colligon T., Yu Q.C., Clemmer V., Zaks T.Z., and Weber B.L. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res. 7 (2005) R1186-R1198
45. Neve R.M., Chin K., Fridlyand J., Yeh J., Baehner F.L., Fevr T., Clark L., Bayani N., Coppe J.-P., Tong F., et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10 (2006) 515-527 this issue
46. Nonet G., Stampfer M., Chin K., Gray J.W., Collins C., and Yaswen P. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res. 61 (2001) 1250-1254
47. Okunieff P., Fenton B.M., Zhang L., Kern F.G., Wu T., Greg J.R., and Ding I. Fibroblast growth factors (FGFS) increase breast tumor growth rate, metastases, blood flow, and oxygenation without significant change in vascular density. Adv. Exp. Med. Biol. 530 (2003) 593-601
48. Ouspenski I.I., Elledge S.J., and Brinkley B.R. New yeast genes important for chromosome integrity and segregation identified by dosage effects on genome stability. Nucleic Acids Res. 27 (1999) 3001-3008
49. Perou C.M., Jeffrey S.S., van de Rijn M., Rees C.A., Eisen M.B., Ross D.T., Pergamenschikov A., Williams C.F., Zhu S.X., Lee J.C., et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. USA 96 (1999) 9212-9217
50. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., et al. Molecular portraits of human breast tumours. Nature 406 (2000) 747-752
51. Pinkel D., Segraves R., Sudar D., Clark S., Poole I., Kowbel D., Collins C., Kuo W.L., Chen C., Zhai Y., et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20 (1998) 207-211
52. Pollack J.R., Perou C.M., Alizadeh A.A., Eisen M.B., Pergamenschikov A., Williams C.F., Jeffrey S.S., Botstein D., and Brown P.O. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 23 (1999) 41-46
53. Pollack J.R., Sorlie T., Perou C.M., Rees C.A., Jeffrey S.S., Lonning P.E., Tibshirani R., Botstein D., Borresen-Dale A.L., and Brown P.O. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. USA 99 (2002) 12963-12968
54. Press M.F., Sauter G., Bernstein L., Villalobos I.E., Mirlacher M., Zhou J.Y., Wardeh R., Li Y.T., Guzman R., Ma Y., et al. Diagnostic evaluation of HER-2 as a molecular target: An assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin. Cancer Res. 11 (2005) 6598-6607
55. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33 (2003) 49-54
56. Ray M.E., Yang Z.Q., Albertson D., Kleer C.G., Washburn J.G., Macoska J.A., and Ethier S.P. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res. 64 (2004) 40-47
57. Reyal F., Stransky N., Bernard-Pierrot I., Vincent-Salomon A., de Rycke Y., Elvin P., Cassidy A., Graham A., Spraggon C., Desille Y., et al. Visualizing chromosomes as transcriptome correlation maps: Evidence of chromosomal domains containing co-expressed genes-A study of 130 invasive ductal breast carcinomas. Cancer Res. 65 (2005) 1376-1383
58. Russ A.P., and Lampel S. The druggable genome: An update. Drug Discov. Today 10 (2005) 1607-1610
59. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin W.J., Stuart S.G., Udove J., Ullrich A., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (1989) 707-712
60. Snijders A.M., Nowak N., Segraves R., Blackwood S., Brown N., Conroy J., Hamilton G., Hindle A.K., Huey B., Kimura K., et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet. 29 (2001) 263-264
61. Snijders A.M., Fridlyand J., Mans D.A., Segraves R., Jain A.N., Pinkel D., and Albertson D.G. Shaping of tumor and drug-resistant genomes by instability and selection. Oncogene 22 (2003) 4370-4379
62. Solinas-Toldo S., Lampel S., Stilgenbauer S., Nickolenko J., Benner A., Dohner H., Cremer T., and Lichter P. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20 (1997) 399-407
63. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98 (2001) 10869-10874
64. Sorlie T., Tibshirani R., Parker J., Hastie T., Marron J.S., Nobel A., Deng S., Johnsen H., Pesich R., Geisler S., et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA 100 (2003) 8418-8423
65. Still I.H., Hamilton M., Vince P., Wolfman A., and Cowell J.K. Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon. Oncogene 18 (1999) 4032-4038
66. Takahashi S., Suzuki S., Inaguma S., Cho Y.M., Ikeda Y., Hayashi N., Inoue T., Sugimura Y., Nishiyama N., Fujita T., et al. Down-regulation of Lsm1 is involved in human prostate cancer progression. Br. J. Cancer 86 (2002) 940-946
67. Tanaka S., Sugimachi K., Kawaguchi H., Saeki H., Ohno S., and Wands J.R. Grb7 signal transduction protein mediates metastatic progression of esophageal carcinoma. J. Cell. Physiol. 183 (2000) 411-415
68. Tanner M.M., Tirkkonen M., Kallioniemi A., Collins C., Stokke T., Karhu R., Kowbel D., Shadravan F., Hintz M., Kuo W.L., et al. Increased copy number at 20q13 in breast cancer: Defining the critical region and exclusion of candidate genes. Cancer Res. 54 (1994) 4257-4260
69. van de Vijver M.J., He Y.D., van 't Veer L.J., Dai H., Hart A.A., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347 (2002) 1999-2009
70. van 't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
71. Vogel C.L., Cobleigh M.A., Tripathy D., Gutheil J.C., Harris L.N., Fehrenbacher L., Slamon D.J., Murphy M., Novotny W.F., Burchmore M., et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J. Clin. Oncol. 20 (2002) 719-726
72. Weber-Mangal S., Sinn H.P., Popp S., Klaes R., Emig R., Bentz M., Mansmann U., Bastert G., Bartram C.R., and Jauch A. Breast cancer in young women (≤35 years): Genomic aberrations detected by comparative genomic hybridization. Int. J. Cancer 107 (2003) 583-592
73. Yeung K.Y., Fraley C., Murua A., Raftery A.E., and Ruzzo W.L. Model-based clustering and data transformations for gene expression data. Bioinformatics 17 (2001) 977-987
74. Yeung K.Y., Medvedovic M., and Bumgarner R.E. From co-expression to co-regulation: How many microarray experiments do we need?. Genome Biol. 5 (2004) R48
75. Yi Y., Mirosevich J., Shyr Y., Matusik R., and George Jr. A.L. Coupled analysis of gene expression and chromosomal location. Genomics 85 (2005) 401-412
76. Zhu Y., Kan L., Qi C., Kanwar Y.S., Yeldandi A.V., Rao M.S., and Reddy J.K. Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR. J. Biol. Chem. 275 (2000) 13510-13516